跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NTM
首页
药物
NTM
NTM
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Use of specific phages for the treatment of nontuberculosis mycobacteria (NTM) infections
申请人: UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
优先权: 2022
US
MYCOBACTERIOPHAGE FUNCTIONALIZED MAGNETIC NANOCRYSTAL CLUSTERS FOR HIGHLY SENSITIVE DETECTION OF TUBERCULOSIS AND NON-TUBERCULOSIS MYCOBACTERIUM (NTM) RELATED INFECTION
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2024
WO
ANTI-NON-TUBERCULOUS MYCOBACTERIA INHIBITORS
申请人: UNIV NANYANG TECH
优先权: 2024
WO
Application of PRKCB gene
申请人: SHANGHAI PULMONARY HOSPITAL SHANGHAI OCCUPATIONAL DISEASE PREVENTION AND TREAT INSTITUTE
优先权: 2023
CN
Method and system for identifying mycobacterium tuberculosis infection and non-tuberculous mycobacteria infection and application
申请人: BEIJING ENYUANHUA BIOLOGICAL TECH CO LTD
优先权: 2020
CN
Method for diagnosing of Mycobacterium tuberculosis
申请人: ASIAGEN CORP
优先权: 2008
US
Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
申请人: UNIV VANDERBILT
优先权: 2014
US
9 件公开
Application of zinc pyrithione and derivative
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
药物
反馈